Finance

Lists
Q2 2027 earnings • released • Revenue beat +10.94%
See results
MDP:TSE
Medexus Pharmaceuticals Inc
CA$5.43
-4.57%
(-0.26) 1D
Nov 13, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MDP...
Open
CA$5.69
High
CA$5.69
Low
CA$5.37
Mkt. cap
173.90M
Avg. vol.
37.81K
Volume
59.15K
P/E ratio
50.97
52-wk high
CA$5.72
52-wk low
CA$2.51
EPS
CA$0.11
Beta
1.53
Shares outstanding
31.43M
No. of employees
102
Open
CA$5.69
High
CA$5.69
Low
CA$5.37
Mkt. cap
173.90M
Avg. vol.
37.81K
Volume
59.15K
P/E ratio
50.97
52-wk high
CA$5.72
52-wk low
CA$2.51
EPS
CA$0.11
Beta
1.53
Shares outstanding
31.43M
No. of employees
102
News stories
From web sources and news partners
About Medexus Pharmaceuticals Inc
CEO-
Employees102
Founded2000
HeadquartersToronto, Ontario, Canada
SectorHealth Care
IndustryPharmaceutical industry
Websitemedexus.com
Last report
Nov 12, 2026
Fiscal period
Q2 2027
- / -
Revenue / Est. (CAD)
41.44M / 37.35M
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
25.32M
24.65M
28.58M
-
Cost of goods sold
9.39M
9.00M
10.34M
-
Cost of revenue
9.39M
9.00M
10.34M
-
Research and development expenses
617.00K
951.00K
728.00K
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.22M
10.59M
12.99M
-
Operating expense
14.26M
14.00M
16.13M
-
Total operating expenses
23.65M
23.00M
26.47M
-
Operating income
1.68M
1.66M
2.11M
-
Other non operating income
132.00K
-1.01M
-
-
EBT including unusual items
446.00K
-3.01M
501.00K
-
EBT excluding unusual items
446.00K
-129.00K
501.00K
-
Income tax expense
366.00K
-333.00K
-43.00K
-
Effective tax rate
82.06%
11.07%
-8.58%
-
Other operating expenses
-
-
-
-
Net income
80.00K
-2.68M
544.00K
-
Net profit margin
0.32%
-10.85%
1.90%
2.79%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-1.36M
-1.03M
-1.25M
-
Net interest expenses
-1.36M
-1.03M
-1.25M
-
Depreciation and amortization charges
70.00K
75.00K
70.00K
-
EBITDA
4.10M
3.94M
4.53M
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps